WHO ICTRP trial
Defining the Histopathological Extent of Resection in Glioma: Is there R0…
DRKS00037773 · German Clinical Trials Register · Recruiting
Key facts
| Trial ID | DRKS00037773 |
|---|---|
| Public title | Defining the Histopathological Extent of Resection in Glioma: Is there R0 Resection in Glioma Surgery? – HighResection Glio (HiResGlio) – A Pilot Study |
| Scientific title | Defining the Histopathological Extent of Resection in Glioma: Is there R0 Resection in Glioma Surgery? – HighResection Glio (HiResGlio) – A Pilot Study - HiResGlio |
| Primary sponsor | Klinik für Neurochirurgie |
| Registry | German Clinical Trials Register |
| Recruitment status | Recruiting |
| Study type | observational |
| Countries | Germany |
| Conditions | D43;Neoplasm of uncertain or unknown behaviour of brain and central nervous system |
| Interventions | Group 1: Non-eloquent gliomas (supramaximal resection + intraoperative histopathological assessment of resection margins) |
| Registration date | Oct 9, 2025 |
| Target size | 30 |
| Secondary IDs | 2022-717 |
| Registry page | drks.de |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: